2nd Wednesday Educational Series
Does Race and Ethnicity Matter?
Date: Wednesday, January 14, 2026
7:30 – 8:30 pm EDT
Location: Virtual - Horizon Virtual Venue Platform & Zoom

Program Learning Objectives – At the conclusion of this activity participants will be able to:
-
Describe factors that affect race and ethnicity in pharmacotherapy
-
Express the relation between pharmacokinetics and clinical response
-
Identify barriers to disparities in care by race and ethnicity
Presenter: William B. Lawson, MD, PhD, DLFAPA
William B. Lawson, MD, PhD, DLFAPA is Founder of the Institute for Reducing Disparities, LLC, Immediate Past President of Senior Psychiatrists Inc, Professor of Psychiatry and Behavioral Sciences at the George Washington University, Emeritus Professor of psychiatry and Associate Dean for Diversity at the Dell Medical School, University of Texas, Austin, and emeritus professor and formerly chair of psychiatry and behavioral sciences at Howard University School of Medicine. He received a PhD in Psychology from the University of New Hampshire and MD from the Pritzker School of Medicine, University of Chicago, residency at Stanford University and fellowship at the National Institute of Mental Health. He has held faculty positions at the University of Illinois, Urbana, University of California, Irvine, Vanderbilt University, University of Arkansas, and Howard University. He was past Presidents of the DC chapter, Mental Health America, the Washington Psychiatric Society, and Black Psychiatrists of America. He received the American Psychiatric Foundation Award for Advancing Minority Mental Health, the Jeanne Spurlock Award, and the Solomon Carter Fuller Award by the American Psychiatric Association, the National Alliance for the Mentally Ill Exemplary Psychiatrist Award, and the George Winokur Clinical Research Award from the American Academy of Clinical Psychiatrists. He has over 200 publications, and former editor in chief of the Journal of the National Medical Association. His newest book is “African American Health”.
Accreditation and Designation Statement
In support of improving patient care, this activity has been planned and implemented by American Psychiatric Association (APA) and Washington Psychiatric Society. The American Psychiatric Association (APA) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The American Psychiatric Association (APA) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.